Thieno-pyridine derivatives as MEK inhibitors
US8394822B2 · kind B2 · utility
11Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2012 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Sep 5, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.